Literature DB >> 26271194

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.

Nina Worel1, Andreas Buser2, Hildegard T Greinix3, Hans Hägglund4, Willis Navarro5, Michael A Pulsipher6, Grazia Nicoloso de Faveri7, Mats Bengtsson8, Annelies Billen9, German Espino10, Mirjam Fechter11, Valeria Giudice12, Kristina Hölig13, Heiwa Kanamori14, Yoshihisa Kodera15, Gerda Leitner16, Tanja Netelenbos17, Dietger Niederwieser18, Suzanna M van Walraven19, Vanderson Rocha20, Tigran Torosian21, Carmen Vergueiro22, Daniel Weisdorf23, Hiromasa Yabe24, Jörg P Halter25.   

Abstract

The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year continues to increase. Advances in HLA typing, better supportive care, and administration of reduced-intensity conditioning regimens allow treatment of older patients with older sibling donors. Pretransplant donor assessment and testing are very important processes affecting the quality and safety of donation. For unrelated HSC donors detailed recommendations for health assessment have been published, allowing donation only if they are unrestrictedly healthy. Eligibility criteria for related donors are less strict and vary significantly between centers. In situations where a family donor does not meet the suitability criteria for unrelated donors, involved physicians often struggle with the decision whether the matched relative is suitable for donation or not. On behalf of the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues, we intended to develop a consensus document with recommendations for donor workup and final clearance of family donors who would not be able to serve as unrelated donors because of their age or pre-existing diseases. This article covers different topics intending to support decision-making, with the goal of minimizing medical risk to the donor and protection of the recipient from transmissible diseases.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Related stem cell donor; Suitability criteria

Mesh:

Year:  2015        PMID: 26271194     DOI: 10.1016/j.bbmt.2015.08.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  10 in total

Review 1.  Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.

Authors:  Theo de Witte; David Bowen; Marie Robin; Luca Malcovati; Dietger Niederwieser; Ibrahim Yakoub-Agha; Ghulam J Mufti; Pierre Fenaux; Guillermo Sanz; Rodrigo Martino; Emilio Paolo Alessandrino; Francesco Onida; Argiris Symeonidis; Jakob Passweg; Guido Kobbe; Arnold Ganser; Uwe Platzbecker; Jürgen Finke; Michel van Gelder; Arjan A van de Loosdrecht; Per Ljungman; Reinhard Stauder; Liisa Volin; H Joachim Deeg; Corey Cutler; Wael Saber; Richard Champlin; Sergio Giralt; Claudio Anasetti; Nicolaus Kröger
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

2.  Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Authors:  A Gratwohl; A Sureda; J Cornelissen; J Apperley; P Dreger; R Duarte; H T Greinix; E Mc Grath; N Kroeger; F Lanza; A Nagler; J A Snowden; D Niederwieser; R Brand
Journal:  Leukemia       Date:  2017-03-08       Impact factor: 11.528

3.  Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Authors:  Michael A Pulsipher; Brent R Logan; Pintip Chitphakdithai; Deidre M Kiefer; Marcie L Riches; J Douglas Rizzo; Paolo Anderlini; Susan F Leitman; James W Varni; Hati Kobusingye; RaeAnne M Besser; John P Miller; Rebecca J Drexler; Aly Abdel-Mageed; Ibrahim A Ahmed; Luke P Akard; Andrew S Artz; Edward D Ball; Ruthee-Lu Bayer; Carolyn Bigelow; Brian J Bolwell; E Randolph Broun; Nancy J Bunin; David C Delgado; Katharine Duckworth; Christopher C Dvorak; Theresa E Hahn; Ann E Haight; Parameswaran N Hari; Brandon M Hayes-Lattin; David A Jacobsohn; Ann A Jakubowski; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Michael Linenberger; Mark R Litzow; Walter Longo; Margarida Magalhaes-Silverman; John M McCarty; Joseph P McGuirk; Shahram Mori; Vinod K Prasad; Scott D Rowley; Witold B Rybka; Indira Sahdev; Jeffrey R Schriber; George B Selby; Paul J Shaughnessy; Shalini Shenoy; Thomas Spitzer; William T Tse; Joseph P Uberti; Madhuri Vusirikala; Edmund K Waller; Daniel J Weisdorf; Gregory A Yanik; Willis H Navarro; Mary M Horowitz; Galen E Switzer; Bronwen E Shaw; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-10       Impact factor: 5.742

4.  Passenger Lymphocyte Syndrome and Autoimmune Hypothyroidism Following Hematopoietic Stem Cell Transplantation.

Authors:  Denis F Noubouossie; Mohammed I A Zaanona; Luciano J Costa; Huy P Pham; Marisa B Marques; Antonio Di Stasi
Journal:  Case Reports Immunol       Date:  2022-06-23

5.  Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

Authors:  Chloe Anthias; Bronwen E Shaw; Deidre M Kiefer; Jane L Liesveld; Jean Yared; Rammurti T Kamble; Anita D'Souza; Peiman Hematti; Matthew D Seftel; Maxim Norkin; Zachariah DeFilipp; Kimberly A Kasow; Muneer H Abidi; Bipin N Savani; Nirali N Shah; Paolo Anderlini; Miguel A Diaz; Adriana K Malone; Joerg P Halter; Hillard M Lazarus; Brent R Logan; Galen E Switzer; Michael A Pulsipher; Dennis L Confer; Paul V O'Donnell
Journal:  Biol Blood Marrow Transplant       Date:  2015-11-18       Impact factor: 5.742

Review 6.  Decision Analysis of Transplantation for Patients with Myelodysplasia: "Who Should We Transplant Today?"

Authors:  Shukaib Arslan; Ryotaro Nakamura
Journal:  Curr Hematol Malig Rep       Date:  2020-08       Impact factor: 3.952

7.  Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study.

Authors:  Matthew D Seftel; Pintip Chitphakdithai; John P Miller; Hati Kobusingye; Brent R Logan; Michael Linenberger; Andrew S Artz; Ann E Haight; David A Jacobsohn; Mark R Litzow; Margarida Magalhaes-Silverman; George B Selby; Madhuri Vusirikala; Mary M Horowitz; Galen E Switzer; Dennis L Confer; Bronwen E Shaw; Michael A Pulsipher
Journal:  Transplant Cell Ther       Date:  2021-01-15

8.  Bone marrow donation in Poland: 2021 update, and the impact of the coronavirus disease 2019 pandemic on haematopoietic stem cell transplantation.

Authors:  Aleksandra Janowiak-Majeranowska; Filip Lebiedziński; Alan Majeranowski
Journal:  Clin Ethics       Date:  2022-03

9.  Immunological Heterogeneity of Healthy Peripheral Blood Stem Cell Donors-Effects of Granulocyte Colony-Stimulating Factor on Inflammatory Responses.

Authors:  Tor Henrik Anderson Tvedt; Guro K Melve; Galina Tsykunova; Aymen Bushra Ahmed; Annette K Brenner; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2018-09-22       Impact factor: 5.923

10.  Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Authors:  Michael A Pulsipher; Brent R Logan; Deidre M Kiefer; Pintip Chitphakdithai; Marcie L Riches; J Douglas Rizzo; Paolo Anderlini; O'Susan F Leitman; Hati Kobusingye; RaeAnne M Besser; John P Miller; Rebecca J Drexler; Aly Abdel-Mageed; Ibrahim A Ahmed; Luke P Akard; Andrew S Artz; Edward D Ball; Ruthee-Lu Bayer; Carolyn Bigelow; Brian J Bolwell; E Randolph Broun; David C Delgado; Katharine Duckworth; Christopher C Dvorak; Theresa E Hahn; Ann E Haight; Parameswaran N Hari; Brandon M Hayes-Lattin; David A Jacobsohn; Ann A Jakubowski; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Michael Linenberger; Mark R Litzow; Walter Longo; Margarida Magalhaes-Silverman; John M McCarty; Joseph P McGuirk; Shahram Mori; Vinod Parameswaran; Vinod K Prasad; Scott D Rowley; Witold B Rybka; Indira Sahdev; Jeffrey R Schriber; George B Selby; Paul J Shaughnessy; Shalini Shenoy; Thomas Spitzer; William T Tse; Joseph P Uberti; Madhuri Vusirikala; Edmund K Waller; Daniel J Weisdorf; Gregory A Yanik; Willis H Navarro; Mary M Horowitz; Galen E Switzer; Dennis L Confer; Bronwen E Shaw
Journal:  Haematologica       Date:  2018-10-31       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.